Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 53Gastrointestinal 46Genitourinary 26Dermatologic 21Head & Neck 18Gynecologic 17Breast 13Lymphoid 5Other solid neoplasm 4Endocrine 2Sarcoma 1NET 1CNS 1

Conditions

Lymphoma, Non-Hodgkin 767Lymphoma 713Leukemia, Lymphocytic, Chronic, B-Cell 560Lymphoma, Follicular 515Lymphoma, Large B-Cell, Diffuse 440Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Recurrence 317Lymphoma, B-Cell 294Neoplasms 261Lymphoma, Mantle-Cell 251Leukemia 231Multiple Myeloma 189Hodgkin Disease 179Leukemia, Myeloid, Acute 178Lymphoma, B-Cell, Marginal Zone 135Lymphoma, T-Cell, Peripheral 119Burkitt Lymphoma 105Myelodysplastic Syndromes 101Hematologic Neoplasms 100Lymphoma, T-Cell, Cutaneous 88Waldenstrom Macroglobulinemia 84Leukemia, B-Cell 79Lymphoma, T-Cell 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65Lymphoproliferative Disorders 57Hematologic Diseases 57Melanoma 54Carcinoma, Non-Small-Cell Lung 54Breast Neoplasms 51Mycosis Fungoides 49

Interventions

pembrolizumab 5Gemcitabine 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Parkinson Disease 4, Autosomal Dominant Lewy Body × Lymphoid × Clear all
NCT02684292 2026-02-18

MK-3475-204

Merck Sharp & Dohme LLC

Phase 3 Completed
304 enrolled 1 FDA
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03598608 2026-02-05

MK-4280-003

Merck Sharp & Dohme LLC

Phase 1/2 Completed
137 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05508867 2026-01-20

MK-4280A-008

Merck Sharp & Dohme LLC

Phase 2 Completed
203 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03010176 2025-10-29

MK-1454-001

Merck Sharp & Dohme LLC

Phase 1 Completed
156 enrolled 20 charts
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lymphoma

NCT04317066 2025-04-06

KEYNOTE-A33

Merck Sharp & Dohme LLC

Phase 1 Completed
7 enrolled 13 charts
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡